ThioBridge™ Conjugates – Case Study

Your bioconjugate requires specialized expertise and technologies in order to successfully scale up from tox to cGMP clinical batch sizes.

Access our case study entitled ‘ThioBridge Conjugates™’, to learn more about how our ThioBridge™ technology can improve the potency, efficacy, and stability of your ADC program as bridges from preclinical into the clinic.